Literature DB >> 19062123

Olmesartan reduced microalbuminuria in Japanese subjects with type 2 diabetes.

Hiroki Ikeda1, Yoshiyuki Hamamoto, Sachiko Honjo, Koichiro Nabe, Yoshiharu Wada, Hiroyuki Koshiyama.   

Abstract

We investigated the effect of olmesartan on early diabetic nephropathy in hypertensive patients with type 2 diabetes by its replacement of other angiotensin II type 1 receptor blockers (ARBs) by olmesartan. The urinary albumin/creatinine ratio significantly decreased. The present result suggests a possibility that olmesartan may have more effect on early nephropathy than other ARBs.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19062123     DOI： 10.1016/j.diabres.2008.10.013

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  4 in total

Review 1.  Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.

Authors:  Stefano Omboni; Ettore Malacco; Jean-Michel Mallion; Paolo Fabrizzi; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-01-17

2.  ROADMAP and ORIENTAL Trials: the Re-emergence of J-Curve Ghost?

Authors:  Yoshiyuki Hamamoto; Hiroyuki Koshiyama
Journal:  Jpn Clin Med       Date:  2011-06-19

3.  Difference in the effects of switching from candesartan to olmesartan or telmisartan to olmesartan in hypertensive patients with type 2 diabetes: the COTO study.

Authors:  Hiroyuki Daikuhara; Kensaku Fukunaga; Tomie Ohshima
Journal:  Drug Des Devel Ther       Date:  2014-02-17       Impact factor: 4.162

4.  Reduction in urinary albumin excretion with a moderate low-carbohydrate diet in patients with type 2 diabetes: a 12-month intervention.

Authors:  Hajime Haimoto; Tae Sasakabe; Hiroyuki Umegaki; Kenji Wakai
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-13       Impact factor: 3.168
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.